Medlab Clinical has announced the appointment of Joshua David Light as a director, effective November 19, 2024. The initial director’s interest notice reveals that Light currently holds no securities ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Medlab Clinical Ltd faced a delay in ...

Medlab is an Australian ASX-listed biotechnology company finding new ways to address some of the biggest health challenges of our time – including managing depression and opioid-alternatives to pain ...

Microsoft is delighted to announce that Medlab, an ASX-listed biotechnology company with a portfolio of novel medicinal candidates enhanced by its delivery platform and used for the treatment of ...

PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the agency indicated it was more likely to ...

Medlab Clinical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional ...

PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the agency indicated it was more likely to ...